Cargando…

Risk of recurrent thromboembolic events according to treatment duration in patients with superficial vein thrombosis treated with intermediate dose of tinzaparin

OBJECTIVES: To evaluate the risk of symptomatic venous thromboembolism (VTE) recurrence at 3 months in relation to treatment duration, according to baseline risk factor profiles, in patients with superficial vein thrombosis (SVT) treated with intermediate dose of tinzaparin. METHODS: We performed a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karathanos, Christos, Kakkos, Stavros K, Georgiadis, Georgios, Ioannou, Christos, Vasdekis, Spyros, Chatzis, Dimitrios, Latzios, Panagiotis, Giannoukas, Athanasios D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070553/ https://www.ncbi.nlm.nih.gov/pubmed/36461172 http://dx.doi.org/10.1177/02683555221143576

Ejemplares similares

Extended-Duration Treatment of Superficial Vein Thrombosis of the Lower Limbs with Tinzaparin
por: Nikolakopoulos, Konstantinos M., et al.
Publicado: (2018)

Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence
por: Christopoulou, Athina, et al.
Publicado: (2022)

Endovascular Treatment of Infrarenal Abdominal Aortic Aneurysm with Short and Angulated Neck in High-Risk Patient
por: Koutsias, Stylianos, et al.
Publicado: (2013)

Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
por: Trujillo‐Santos, Javier, et al.
Publicado: (2022)

The Role of Tinzaparin in Oncology
por: Dimakakos, Evangelos P., et al.
Publicado: (2017)

Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study
por: Akinosoglou, Karolina, et al.
Publicado: (2022)

Tinzaparin-sodium: Bleeding and deep venous thrombosis: case report
Publicado: (2022)

Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer: A Systematic Review and Meta-Analysis
por: Martínez-Zapata, M. José, et al.
Publicado: (2017)

Tinzaparin vs. Nadroparin Safety and Efficacy in Neurosurgery
por: Wilhelmy, Florian, et al.
Publicado: (2021)

Endografts for the treatment of abdominal aortic aneurysms with a hostile neck anatomy: A systematic review
por: Pitros, Christos, et al.
Publicado: (2022)

CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients
por: Lee, Agnes YY, et al.
Publicado: (2013)

Heparin/tinzaparin-sodium: Lack of efficacy: 3 case reports
Publicado: (2020)

Weight-adjusted dosing of tinzaparin for thromboprophylaxis in obese medical patients
por: Pfrepper, Christian, et al.
Publicado: (2023)

The Impact of Thromboprophylaxis on the Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study
por: Karamouzis, Michalis V., et al.
Publicado: (2021)

Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer
por: Sarantis, Panagiotis, et al.
Publicado: (2021)

Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis
por: Mahmood, Dana, et al.
Publicado: (2010)

Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications
por: Helfer, Hélène, et al.
Publicado: (2019)

Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review
por: Vathiotis, I. A., et al.
Publicado: (2021)

Interpretation of the PREVENT study findings on the adjunctive role of intermittent pneumatic compression to prevent venous thromboembolism
por: Kakkos, Stavros K., et al.
Publicado: (2020)

Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial
por: Muñoz-Rivas, Nuria, et al.
Publicado: (2022)

Single-Bolus Tinzaparin Anticoagulation in Extended Hemodialysis Session: A Feasibility Study
por: Harvey, Benoît, et al.
Publicado: (2023)

Cancer-Associated Thrombosis: Not All Low-Molecular-Weight Heparins Are the Same, Focus on Tinzaparin, A Narrative Review
por: Fioretti, Agnese Maria, et al.
Publicado: (2022)

Superficial Vein Thrombosis and Severe Varicose Veins Complicating Venous Thromboembolism
por: Lee, Sun Hwa, et al.
Publicado: (2019)

The Role of Color Doppler Imaging in the Diagnosis of Glaucoma: A Review of the Literature
por: Banou, Lamprini, et al.
Publicado: (2023)

Spontaneous gall bladder haemorrhage in a renal dialysis patient following haemodialysis with tinzaparin
por: Borman, Natalie, et al.
Publicado: (2010)

Tinzaparin—a review of its molecular profile, pharmacology, special properties, and clinical uses
por: Amerali, Marina, et al.
Publicado: (2022)

Retained Subintimal Pellet in a Carotid Artery
por: Manousi, Maria, et al.
Publicado: (2011)

Tinzaparin and other low-molecular-weight heparins: what is the evidence for differential dependence on renal clearance?
por: Johansen, Kristian B, et al.
Publicado: (2013)

Predictors of 30-Day Postoperative Outcome after Elective Endovascular Abdominal Aortic Aneurysm Repair: A Tertiary Referral Center Experience
por: Ntalouka, Maria P., et al.
Publicado: (2023)

Response to letter to the editor by Dr. Tomoyuki Kawada: “Carotid intima-media thickness and cardiovascular risk in patients with diabetes mellitus type 2 and chronic kidney disease”
por: Georgiadis, George S., et al.
Publicado: (2020)

Tinzaparin Provides Lower Lipid Profiles in Maintenance Hemodialysis Patients: A Cross-Sectional Observational Study
por: Tsai, Ming-Hsien, et al.
Publicado: (2014)

TILE pilot trial study protocol: Tinzaparin Lead-in to Prevent the Post-Thrombotic syndrome study protocol
por: Makedonov, Ilia, et al.
Publicado: (2023)

In Surgical Colon Cancer Patients Extended-Duration Thromboprophylaxis (30 days) with the Highest Dose of Tinzaparin (4,500 IU s.c./q.d.) Normalizes the Postoperative VEGF Levels
por: Mitsis, Michail, et al.
Publicado: (2017)

Vascular Surgery, Quo Vadis?
por: Kakkos, Stavros
Publicado: (2014)

Effects of Antithrombotic Drugs Fondaparinux and Tinzaparin on In Vitro Proliferation and Osteogenic and Chondrogenic Differentiation of Bone-Derived Mesenchymal Stem Cells
por: Papathanasopoulos, Argiris, et al.
Publicado: (2011)

Ruptured true aneurysm of the superficial femoral artery leading to Behçet disease diagnosis
por: Christoforou, Panagitsa, et al.
Publicado: (2022)

Facing a dilemma in the treatment of an internal mammary artery mycotic pseudoaneurysm: coil embolization or surgery? A case report and brief literature review
por: Spiliopoulos, Kyriakos, et al.
Publicado: (2020)

Optimal duration of anticoagulation in patients with venous thromboembolism
por: Prandoni, Paolo, et al.
Publicado: (2011)

The Low Molecular Weight Heparin Tinzaparin Attenuates Platelet Activation in Terms of Metastatic Niche Formation by Coagulation-Dependent and Independent Pathways
por: Gockel, Lukas Maria, et al.
Publicado: (2018)

1st International Symposium and 10th Balkan Conference on Operational Research
por: Migdalas, Athanasios, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rkm1736kke1kck9dfr16b6f9tv